Press Releases
MARKHAM, Ontario, May 09, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“Sienna” or the “Company”) (TSX: SIA) today announced its financial results for the three months ended March 31, 2024. The Consolidated Financial Statements and accompanying Management’s Discussion and Analysis (“MD&A”) are available on the Company’s website at www.siennaliving.ca and on SEDAR+ at www.sedarplus.ca.
Sienna continued its trend of year over year same... (continue reading...)
WHEATON, Ill.--(BUSINESS WIRE)-- First Trust Advisors L.P. ("FTA") announces the declaration of the monthly distribution for FT Energy Income Partners Enhanced Income ETF, advised by FTA.
The following dates apply to today's distribution declarations:
Expected Ex-Dividend Date:
May 21, 2024
Record Date:
May 22, 2024
Payable Date:
May 31,... (continue reading...)
Astrotech (NASDAQ: ASTC), a science and technology development and commercialization company, and its wholly owned subsidiary, AgLAB Inc., have developed a mass spectrometer designed for use in the hemp and cannabis market. “During the process of converting cannabis biomass into distillate, valuable cannabinoids are typically lost, resulting in reduced profits. AgLAB’s Maximum Value Processing (‘MVP’) method uses the powerful AgLAB-1000-D2 mass spectrometer to... (continue reading...)
Increased Total Orders by 13.7% and Repeat Orders by Over 20% Year-Over-YearIncreased First Quarter 2024 Gross Margin by 500 bps to 59.9%Generated GAAP Diluted EPS of $0.01 and Adjusted Diluted EPS of $0.03Exceeded Profitability ExpectationsReiterates Fiscal 2024 Guidance
SAN FRANCISCO, May 09, 2024 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (Nasdaq: BRLT), an innovative, global leader in ethically sourced fine... (continue reading...)
Phase 3 clinical trial evaluating F351 for the treatment of CHB-associated liver fibrosis in the PRC remains on track with data anticipated by early 2025
U.S. IND submission to evaluate F351 for the treatment of NASH-associated liver fibrosis expected in late 2024; Phase 2a trial expected to initiate in 2025
Acquired the rights to complementary assets relating to nintedanib through Gyre Pharmaceuticals to improve competitiveness in the PRC
Cash and cash... (continue reading...)
More Press Releases
View Older Stories-
TerrAscend Reports First Quarter 2024 Financial Results
-
Karat Packaging Reports 2024 First Quarter Financial Results
-
Anaptys Announces Positive Top-Line GEMINI-2 Phase 3 Clinical Trial Results of Imsidolimab (IL-36R) in Generalized Pustular Psoriasis (GPP)
-
Ayala Pharmaceuticals Files Form 15 to Voluntarily Deregister and Suspend its Reporting Obligations
-
CSB Bancorp, Inc. Declares Second Quarter Cash Dividend
-
Xencor Reports First Quarter 2024 Financial Results
-
Cohu to Present at Upcoming Investor Conferences
-
HireQuest Reports Financial Results for First Quarter 2024
-
Intensity Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
-
Heritage Global Inc. Reports First Quarter 2024 Results
-
The Next Chapter: $1 Billion of Strategic, Accretive Northern Delaware Transactions and Divestiture of its 16% Interest in the Gulf Coast Express Pipeline
-
RCI Reports 2Q24 Results; X Spaces Call at 4:30 PM ET Today; Meet Management at 7 PM ET Tonight
-
Guanajuato Silver Announces Closing of C$11.35 Million Brokered Financing
-
Getty Images Reports First Quarter 2024 Results
-
MicroVision Announces First Quarter 2024 Results
-
ACWA Honors East Valley Water District for its Innovative, Multi-Beneficial Wastewater Treatment Facility
-
Four California College Students Awarded ACWA Scholarships
-
Savers Value Village, Inc. Reports First Quarter Financial Results and Acquisition of Thrift Store Chain with Seven Locations in Georgia
-
Rigetti Computing Reports First Quarter 2024 Financial Results
-
Funko Reports First Quarter 2024 Financial Results; Reiterates Full-Year Outlook for 2024
-
Canterbury Park Holding Corporation Reports First Quarter Results
-
Americold Announces First Quarter 2024 Results
-
Acacia Research Reports First Quarter 2024 Financial Results
-
Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update
-
eGain Reports Continued Momentum in New Logo Wins Driven by AI Knowledge Offering
-
CareDx Reports First Quarter 2024 Results
-
Aqua Metals to Announce First Quarter 2024 Financial Results and Host Investor Conference Call on May 15, 2024
-
Pinterest Appoints Chip Bergh to Board of Directors
-
Savers Value Village, Inc. Names Michael Maher as Chief Financial Officer
-
Haynes International, Inc. Reports Second Quarter Fiscal 2024 Financial Results
-
Array Technologies, Inc. Reports Financial Results for the First Quarter 2024 – Achieves record gross margin and $2.1 billion of executed contracts and awarded orders
-
Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant Seizures
-
Phunware Reports Significant Improvement in First Quarter 2024 Financial Results
-
Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold
-
Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate Highlights
-
INmune Bio Inc. Announces First Quarter 2024 Results and Provides Business Update
-
Revance Expands into the U.S. Therapeutics Market with the Launch of DAXXIFY® for the Treatment of Cervical Dystonia
-
Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
-
Mobivity Schedules First Quarter 2024 Conference Call for Wednesday, May 15, 2024
-
Ark Restaurants Announces Conference Call
-
Brightcove to Present at the Needham Technology, Media & Consumer Conference
-
American Vanguard Reports Q1 2024 Results
-
Onto Innovation Reports 2024 First Quarter Results
-
Arlo Reports First Quarter 2024 Results
-
Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
-
Bloom Energy Reports First Quarter 2024 Financial Results
-
Evolv Technology Reports First Quarter Financial Results
-
REPAY Reports First Quarter 2024 Financial Results
-
Granite Ridge Resources Inc. Reports First Quarter 2024 Results
-
Sweetgreen, Inc. Announces First Quarter 2024 Financial Results